Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-03-29

Clinical Trial Update: Comparing Fluticasone-salmeterol in Chronic Obstructive Pulmonary Disease (COPD) and Sleep [Phase 4]

View source ↗

Summary

Phase 4 trial update comparing fluticasone-salmeterol in COPD, with results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluticasone/Salmeterol (fluticasone/salmeterol)

Snippet

Sponsor: Milton S. Hershey Medical Center | Conditions: COPD | Phase 4 | Status: COMPLETED | Results posted: 2019-03-29